Proline protects liver from D-galactosamine hepatitis by activating the IL-6/STAT3 survival signaling pathway

Amino Acids

Volumn 43, Issue 6, 2012, Pages 2371-2380

  Obayashi, Yoko ^a,b   Arisaka, Harumi ^a   Yoshida, Shintaro ^a   Mori, Masato ^a   Takahashi, Michio ^a  

^a AJINOMOTO CO INC   (Japan)

^b NONE   (Japan)

Author keywords

D Galactosamine; IL 6; Liver; Proline; STAT3; TNF A

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GALACTOSAMINE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PROLINE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FISCHER 344 RAT; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INFLAMMATION; LIVER PROTECTION; LIVER REGENERATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; TOXIC HEPATITIS; UPREGULATION;

ANIMALIA; RATTUS;

EID: 84872675816     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1317-8     Document Type: Article

References (32)

1. Adams E, Frank L (1980) Metabolism of proline and the hydroxyprolines. Annu Rev Biochem 49:1005-1061. doi:10.1146/annurev. bi.49.070180.005041
2. Ajinomoto Co., Inc. (1996) Japan Patent Kokai 1996-169063
3. Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X et al (2002) Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 35:40-48. doi:10.1053/jhep2002. 30081 (Pubitemid 34032542)
4. Chen Lf, Fischle W, Verdin E, Greene WC (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653-1657. doi:10.1126/science.1062374 (Pubitemid 32807844)
5. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383. doi:10.1126/science.274. 5291.1379 (Pubitemid 26391463)
6. Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D et al (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 61:1810-1815 (Pubitemid 32691989)
7. Fujiyoshi M, Ozaki M (2011) Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci 18(1):13-22
8. Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72:1493-1505. doi:10.1016/j.bcp.2006.04.011 (Pubitemid 44666727)
9. Grun M, Liehr H, Rasenack U (1977) Significance of endotoxaemia in experimental galactosamine-hepatitis in the rat. Acta Hepatogastroenterol (Stuttg) 24:64-81 (Pubitemid 8074406)
10. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H et al (2003) Stat3 protects against Fas-induced liver injury by redoxdependent and-independent mechanisms. J Clin Invest 112:989-998. doi:10.1172/JCI200317970 (Pubitemid 38056314)
11. Hagedorn CH, Phang JM (1983) Transfer of reducing equivalents into mitochondria by the interconversions of proline and delta1-pyrroline-5- carboxylate. Arch Biochem Biophys 225:95-101. doi:10.1016/0003-9861(83)90010-3
12. Hawkins RL, Mori M, Inoue M, Torii K (1995) Proline, ascorbic acid, or thioredoxin affect jaundice and mortality in Long Evans cinnamon rats. Pharmacol Biochem Behav 52:509-515. doi: 10.1016/0091-3057(95)00118-G
13. Itokazu Y, Segawa Y, Inoue N, Omata T (1999) D-galactosamineinduced mouse hepatic apoptosis: possible involvement with tumor necrosis factor, but not with caspase-3 activity. Biol Pharm Bull 22:1127-1130 (Pubitemid 29507958)
14. Jirillo E, Caccavo D, Magrone T, Piccigallo E, Amati L, Lembo A et al (2002) The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res 8:319-327. doi:10.1177/09680519020080050501 (Pubitemid 35460666)
15. Kirillova I, Chaisson M, Fausto N (1999) Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ 10:819-828 (Pubitemid 30036254)
16. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31:149-159. doi: 10.1002/hep510310123 (Pubitemid 30033701)
17. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R (2001) Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-Apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276:26605-26613. doi: 10.1074/jbc.M100740200 (Pubitemid 37412883)
18. Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z et al (2009) Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15:283-293. doi:10.1016/j.ccr. 2009.02.015
19. Li W, Liang X, Kellendonk C, Poli V, Taub R (2002) STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277:28411-28417. doi:10.1074/jbc. M202807200 (Pubitemid 41079264)
20. Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, Taub R (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33:1377-1386. doi:10.1053/jhep2001.24431 (Pubitemid 32496974)
21. MacDonald JR, Beckstead JH, Smuckler EA (1987) An ultrastructural and histochemical study of the prominent inflammatory response in D (?)-galactosamine hepatotoxicity. Br J Exp Pathol 68:189-199 (Pubitemid 17051485)
22. Matsumoto T, O'Malley K, Efron PA, Burger C, McAuliffe PF, Scumpia PO et al (2006) Interleukin-6 and STAT3protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 140:793-802. doi:10.1016/j. surg.2006.04.010 (Pubitemid 44648189)
23. Moh A, Iwamoto Y, Chai GX, Zhang SS, Kano A, Yang DD et al (2007) Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 87:1018-1028. doi:10.1038/labinvest.3700630 (Pubitemid 47429186)
24. Phang JM (1985) The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr Top Cell Regul 25:91-132
25. Schuringa JJ, Dekker LV, Vellenga E, Kruijer W (2001) Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J Biol Chem 276(29):27709-27715. doi:10.1074/jbc.M009821200
26. Singh A, Jayaraman A, Hahn J (2006) Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes. Biotechnol Bioeng 95(5):850-862. doi:10.1002/bit.21026 (Pubitemid 44863203)
27. Teoh N, Leclercq I, Pena AD, Farrell G (2003) Low-dose TNF-Alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 37(1):118-128. doi:10.1053/jhep2003.50009 (Pubitemid 36042152)
28. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I et al (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49. doi:10.1016/S1074-7613(00) 80005-9 (Pubitemid 29077382)
29. Taub R (2003) Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 112:978-980. doi:10.1172/JCI200319974 (Pubitemid 38056310)
30. Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, Knabe DA, Li P, Li X, McKnight JR, Satterfield MC, Spencer TE (2011) Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids 40(4):1053-1063. doi: 10.1007/s00726-010-0715-z
31. Vemura RP, Aragona E, Gupta S (1992) Analysis of hepatocelluar proliferation: study of archival liver tissue is facilitated by an endogenous marker of DNA replication. Hepatology 16:968-973
32. Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A et al (1998) NF-kappaB inactivation converts a hepatocyte cell line TNF-Alpha response from proliferation to apoptosis. Am J Physiol 275(4 Pt 1):C1058-C1066